Acclaro Medical, a Smithfield, RI-based medical expertise firm targeted on growing options for affected person care and medical practices, raised $23M in Collection B funding.
The spherical was led by Accelmed Companions with participation from present investor 3E Bioventures Capital.
The corporate intends to make use of the funds to speed up the expansion of its flagship merchandise, UltraClear and AuraLux, and expedite international market growth whereas advancing improvement of latest merchandise in its pipeline.
Led by CEO Helen Fang, Acclaro Medical develops innovates and brings to market options to handle unmet medical, aesthetic and surgical follow wants. Its flagship product, UltraClear, is a chilly, ablative fiber laser platform, a painless anti-aging answer not requiring topical numbing for many remedies. Empowered by the 3DMIRACL and 3DIntelliPulse applied sciences, the corporate presents a full vary of pores and skin rejuvenation outcomes from painless and zero-downtime anti-aging lunchtime remedies to most superior collagen reworking.
FinSMEs
29/05/2025
